News
-
-
COMMUNIQUÉ DE PRESSE
General Meeting of mobilezone holding ltd approves a dividend of CHF 0.90 (previous year: CHF 0.90)
General Meeting of mobilezone holding ltd approves a dividend of CHF 0.90. Shareholders vote on various proposals, including discharge of Board, dividend payout, and re-election of Board members -
-
-
-
COMMUNIQUÉ DE PRESSE
Xlife Sciences AG Announces Collaboration Agreement Between its Portfolio Company FUSE-AI GmbH and T-Systems Switzerland
Xlife Sciences AG announces collaboration agreement between its portfolio company FUSE-AI GmbH and T-Systems Switzerland to distribute AI-powered software for radiology clinics. The partnership aims to increase efficiency and reduce misdiagnoses -
COMMUNIQUÉ DE PRESSE
Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature
Moderna, Inc. announced interim data for mRNA-3927 therapy for propionic acidemia published in Nature, showing signs of clinical benefit and safety. Ongoing global trial evaluates safety and efficacy in participants with PA -
-
-